The medical aesthetics market in North America is expected to grow from US$ 2,512.24 million in 2021 to US$ 5,823.87 million by 2028; it is estimated to grow at a CAGR of 12.8% from 2021 to 2028.
The US, Canada, and Mexico are major economies in North America. Increasing use of dermal fillers and botulinum toxin for enhancing facial aesthetics is the major factor driving the growth of the North America medical aesthetics market. Over the past two decades, there has been an unprecedented surge in the popularity of elective aesthetic procedures. Moreover, there is an increasing demand for less invasive aesthetic procedures such as dermal fillings and botulinum toxin A (BoNTA). The global statistics of the International Society of Aesthetic Plastic Surgery indicates the rise in the aesthetic applications of BoNTA and dermal filling implants by 7% and 18%, respectively, during 2015–2016. Nonsurgical facial rejuvenation using botulinum toxin and hyaluronic acid has become highly popular in the Middle East and other parts of the world in the last 10 years. The correction of facial rhythm and loss of volume is the basic principle of aesthetic rejuvenation of the face. Botulinum toxin injections are primarily indicated to correct dynamic rhytides, while dermal fillers aim to increase volume and improve static rhytides. Botulinum toxin, a powerful neurotoxin, causes chemodenervation of muscles. Dermal fillers is a non-energy-based procedure that adds volume and fullness to a person's skin. The cost efficiency and increasing aging population are the key factors driving the demand for dermal fillers. Further, surge in demand for superior materials and techniques required for dental aesthetics procedures has spurred research into the same. However, nonsurgical facial aesthetic procedures received less attention from the dental community until chemicals such as hyaluronic acid fillers and botulinum toxin were requested by patients, which led dental manufacturers to add these materials to their catalogs and advertisements. The increasing number of accredited basic and advanced hands-on training courses in the use of such materials has been advertised in most dental journals and journals that are currently available. Facial rejuvenation has become a major issue of psychosocial wellbeing in this era of fashion, beauty, and trends. Thus, the increasing use of dermal fillers and botulinum toxin for enhancing facial aesthetics is fueling the
medical aesthetics market growth.
In the US, healthcare professionals and leading organizations are distracting the flow of healthcare resources from research & development to primary care due to an increasing number of COVID-19 patients. This scenario is slowing down the process of innovation. Moreover, the cosmetic surgeons having a unique perspective of working with patients and their teams create difficulties and challenges in the time of distress. Due to the ongoing COVID-19 pandemic, in May 2020, the American Society of Plastic Surgeons (ASPS) released a statement to urge the suspension of elective and nonessential procedures of cosmetic and laser surgeries in the US.The ASPS also stated that the necessary action is likely to result in detrimental financial effect on the aesthetic surgery community. However, the organization is putting in its best efforts to continue the consultations for medical interventions through virtual platforms. The ASPS is encouraging the use of telehealth to arrange the preoperative consults and follow-up appointments of the post-operative patients.In addition, the cosmetic surgery societies are implementing strategies to curb the financial losses and have amended their policies to support small businesses. For instance, Small Business Administration offering expanded disaster impact loans and deferment of the federal income tax payments by three months to July 15.
North America Medical Aesthetics Market Segmentation
North America Medical Aesthetics Market – By Product
- Facial Aesthetic Products
- Dermal Fillers
- Botulinum Toxin
- Microdermabrasion Devices
- Body Contouring Devices
- Liposuction Devices
- Nonsurgical Fat Reduction Devices
- Cellulite Reduction Devices
- Cosmetic Implants
- Breast Implants
- Facial Implants
- Others
- Skin Aesthetic Devices
- Laser Skin Resurfacing Devices
- Light Therapy Devices
- Nonsurgical Skin Tightening Devices
- Micro-Needling Products
- Hair Removal Devices
- Tattoo Removal Devices
- Others
North America Medical Aesthetics Market – By Application
- Facial and Body Contouring
- Facial and Skin Rejuvenation
- Breast Augmentation
- Hair Removal
- Reconstructive Surgery
- Tattoo Removal
- Others
North America Medical Aesthetics Market – By End User
- Hospitals
- Dermatology Clinics
- Medical Spas and Beauty Centers
- Home Care
North America Medical Aesthetics Market– By Country
North America Medical Aesthetics Market-Companies Mentioned
- Allergan Plc
- Alma Lasers
- Cutera Inc
- Galderma
- Hologic, Inc.
- Mentor Worldwide, LLC
- Sientra
- Solta Medical
North America Medical Aesthetics Report Scope
| Report Attribute |
Details |
| Market size in 2021 |
US$ 2,512.24 Million |
| Market Size by 2028 |
US$ 5,823.87 Million |
| Global CAGR (2021 - 2028) |
12.8% |
| Historical Data |
2019-2020 |
| Forecast period |
2022-2028 |
| Segments Covered |
By Product - Facial Aesthetic Products
- Cosmetic Implants
- Body Contouring Devices
- Skin Aesthetic Devices
- Hair Removal Devices
- Tattoo Removal Devices
By Application - Facial and Body Contouring
- Facial and Skin Rejuvenation
- Breast Augmentation
- Hair Removal
- Reconstructive Surgery
- Tattoo Removal
By End User - Hospitals
- Dermatology Clinics
- Medical Spas and Beauty Centers
- Home Care
|
| Regions and Countries Covered |
North America |
| Market leaders and key company profiles |
Allergan Plc
Alma Lasers
Cutera Inc
Galderma
Hologic, Inc.
Mentor Worldwide, LLC
Sientra
Solta Medical |